Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a mur...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2014
|
| _version_ | 1797075526730383360 |
|---|---|
| author | Poyntz, H Stylianou, E Griffiths, K Griffiths, K Marsay, L Checkley, A Checkley, A McShane, H |
| author_facet | Poyntz, H Stylianou, E Griffiths, K Griffiths, K Marsay, L Checkley, A Checkley, A McShane, H |
| author_sort | Poyntz, H |
| collection | OXFORD |
| description | The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a murine model to determine the effect that exposure to NTM after BCG vaccination had on the efficacy of BCG against aerosol Mycobacterium tuberculosis challenge. The effects of administering live Mycobacterium avium (MA) by an oral route and killed MA by a systemic route on BCG-induced protection were evaluated. CD4+ and CD8+ T cell responses were profiled to define the immunological mechanisms underlying any effect on BCG efficacy. BCG efficacy was enhanced by exposure to killed MA administered by a systemic route; T helper 1 and T helper 17 responses were associated with increased protection. BCG efficacy was reduced by exposure to live MA administered by the oral route; T helper 2 cells were associated with reduced protection. These findings demonstrate that exposure to NTM can induce opposite effects on BCG efficacy depending on route of exposure and viability of NTM. A reproducible model of NTM exposure would be valuable in the evaluation of novel TB vaccine candidates. © 2014 Elsevier Ltd. All rights reserved. |
| first_indexed | 2024-03-06T23:51:32Z |
| format | Journal article |
| id | oxford-uuid:72c4aa9b-2e86-486c-baf0-1021ce478f54 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:51:32Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:72c4aa9b-2e86-486c-baf0-1021ce478f542022-03-26T19:52:12ZNon-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:72c4aa9b-2e86-486c-baf0-1021ce478f54Symplectic Elements at Oxford2014Poyntz, HStylianou, EGriffiths, KGriffiths, KMarsay, LCheckley, ACheckley, AMcShane, HThe efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a murine model to determine the effect that exposure to NTM after BCG vaccination had on the efficacy of BCG against aerosol Mycobacterium tuberculosis challenge. The effects of administering live Mycobacterium avium (MA) by an oral route and killed MA by a systemic route on BCG-induced protection were evaluated. CD4+ and CD8+ T cell responses were profiled to define the immunological mechanisms underlying any effect on BCG efficacy. BCG efficacy was enhanced by exposure to killed MA administered by a systemic route; T helper 1 and T helper 17 responses were associated with increased protection. BCG efficacy was reduced by exposure to live MA administered by the oral route; T helper 2 cells were associated with reduced protection. These findings demonstrate that exposure to NTM can induce opposite effects on BCG efficacy depending on route of exposure and viability of NTM. A reproducible model of NTM exposure would be valuable in the evaluation of novel TB vaccine candidates. © 2014 Elsevier Ltd. All rights reserved. |
| spellingShingle | Poyntz, H Stylianou, E Griffiths, K Griffiths, K Marsay, L Checkley, A Checkley, A McShane, H Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis |
| title | Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis |
| title_full | Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis |
| title_fullStr | Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis |
| title_full_unstemmed | Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis |
| title_short | Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis |
| title_sort | non tuberculous mycobacteria have diverse effects on bcg efficacy against mycobacterium tuberculosis |
| work_keys_str_mv | AT poyntzh nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT stylianoue nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT griffithsk nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT griffithsk nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT marsayl nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT checkleya nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT checkleya nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis AT mcshaneh nontuberculousmycobacteriahavediverseeffectsonbcgefficacyagainstmycobacteriumtuberculosis |